← Back to guidelines
Cardiology32 papers

Anti-glomerular basement membrane disease

Last edited: 4/15/2026

Overview

Anti-glomerular basement membrane (GBM) disease is an aggressive form of autoimmune glomerulonephritis characterized by vasculitis affecting small vessels, often leading to rapidly progressive glomerulonephritis and crescentic changes 1.

Diagnosis

  • Key Diagnostic Feature: Intense and diffuse linear IgG deposition along the glomerular basement membrane on immunofluorescence 2.
  • Recommended Tests: Serological testing for anti-GBM antibodies and antineutrophil cytoplasmic antibodies (ANCA) 1.
  • Histological Patterns: Light microscopy may reveal crescentic glomerulonephritis and other patterns indicative of rapidly progressive glomerulonephritis 2.
  • Management

  • First-Line Treatment: Plasma exchange (PE) combined with high-dose corticosteroids 1.
  • Adjunctive Therapy: Cyclophosphamide or rituximab may be used in conjunction with corticosteroids for refractory cases 1.
  • Dosage: Specific dosing details not provided in abstracts; consult standard protocols for precise medication dosages 1.
  • Special Populations

  • Pregnancy: No specific data provided in the abstracts regarding management during pregnancy 12.
  • Pediatrics: Limited information available; management likely follows adult protocols with close monitoring 12.
  • Elderly: No distinct recommendations; treatment should consider comorbidities and renal function 12.
  • Comorbidities: Management should account for coexisting conditions, particularly lung hemorrhage, which affects 32.6% of patients 1.
  • Key Recommendations

  • Initiate plasma exchange and high-dose corticosteroids as first-line therapy for confirmed anti-GBM disease (Evidence: Strong 1).
  • Consider cyclophosphamide or rituximab for patients who do not respond adequately to corticosteroids and plasma exchange (Evidence: Moderate 1).
  • Assess kidney function and presence of normal glomeruli at diagnosis as critical prognostic factors (Evidence: Strong 1).
  • References

    1 Kuang H, Jiang N, Jia XY, Cui Z, Zhao MH. Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: A systematic review and meta-analysis. Autoimmunity reviews 2024. link 2 Ferrario F, Rastaldi MP. Histopathological atlas of renal diseases: anti-glomerular basement membrane antibody disease. Journal of nephrology 2005. link

    Original source

    1. [1]
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG